The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Hims & Hers Health Inc shares valued at $40,378 were sold by Boughton Soleil on Aug 06 ’24. At $17.30 per share, Boughton Soleil sold 2,334 shares. The insider’s holdings dropped to 164,475 shares worth approximately $2.58 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Dudum Andrew sold 188,888 shares, netting a total of over 3,110,912 in proceeds. Following the sale of shares at $16.47 each, the insider now holds 33,502 shares.
Before that, Dudum Andrew had sold 144,444 shares from its account. In a trade valued at $2,393,699, the Chief Executive Officer traded Hims & Hers Health Inc shares for $16.57 each. Upon closing the transaction, the insider’s holdings decreased to 144,444 shares, worth approximately $13.98 million.
As published in a research note from Imperial Capital on August 09, 2024, Hims & Hers Health Inc [HIMS] has been rated down from an Outperform to an In-line. Analysts at Citigroup downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in late May. As of April 16, 2024, Jefferies has decreased its “Buy” rating to a “Hold” for HIMS. Earlier on April 10, 2024, Canaccord Genuity initiated its rating. Their recommendation was “a Buy” for HIMS stock.
Analyzing HIMS Stock Performance
During the last five days, there has been a drop of approximately -0.88%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 76.52%. Shares of the company reached a 52-week high of $25.74 on 06/18/24 and a 52-week low of $8.09 on 01/05/24. A 50-day SMA is recorded $20.65, while a 200-day SMA reached $13.65. Nevertheless, trading volume fell to 6.91 million shares from 8.29 million shares the previous day.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 15.49, which, if violated, would cause prices to drop to 15.28. In the upper region, resistance lies at 15.99. The next price resistance is at 16.28. RSI (Relative Strength Index) is 32.70 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.86, which suggests the price will decrease in the coming days. Percent R is at 87.40%, indicating bearish price movement. Stochastics%K at buying indicates that the stock is to be held.
